Molecular point-of-care testing versus conventional RT-PCR for influenza A: Diagnostic performance, clinical decision-making, and costs in a tertiary hospital in Shenzhen, China
Molecular point-of-care testing versus conventional RT-PCR for influenza A: Diagnostic performance, clinical decision-making, and costs in a tertiary hospital in Shenzhen, China. // Journal of Clinical Virology. – URL: https://www.sciencedirect.com/science/article/pii/S1386653226000971?dgcid=rss_sd_all
Molecular point-of-care testing versus conventional RT-PCR for influenza A: Diagnostic performance, clinical decision-making, and costs in a tertiary hospital in Shenzhen, China. Journal of Clinical Virology. https://www.sciencedirect.com/science/article/pii/S1386653226000971?dgcid=rss_sd_all
“Molecular point-of-care testing versus conventional RT-PCR for influenza A: Diagnostic performance, clinical decision-making, and costs in a tertiary hospital in Shenzhen, China.” Journal of Clinical Virology.
@article{article52948,
title = {Molecular point-of-care testing versus conventional RT-PCR for influenza A: Diagnostic performance, clinical decision-making, and costs in a tertiary hospital in Shenzhen, China},
journal = {Journal of Clinical Virology},
url = {https://www.sciencedirect.com/science/article/pii/S1386653226000971?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...